
NOVOCURE LIMITED
Share · JE00BYSS4X48 · NVCR · A140ML (XNAS)
18,20 USD
12.06.2025 20:00
Current Prices from NOVOCURE LIMITED
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
NVCR
|
USD
|
12.06.2025 20:00
|
18,20 USD
| 17,44 USD
+4,36 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 7,06 % | -1,99 % | -11,74 % | -39,45 % | -14,35 % | -71,46 % |
Company Profile for NOVOCURE LIMITED Share
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Invested Funds
The following funds have invested in: NOVOCURE LIMITED invested:
Fund | Vol. in million 374,38 | Percentage (%) 0,67 % |
Fund | Vol. in million 583,71 | Percentage (%) 0,16 % |
Fund | Vol. in million 19,44 | Percentage (%) 0,15 % |
Fund | Vol. in million 480,72 | Percentage (%) 0,04 % |
Fund | Vol. in million 0,14 | Percentage (%) 0,04 % |
Company Data
Name NOVOCURE LIMITED
Company NovoCure Limited
Symbol NVCR
Website
https://www.novocure.com
Primary Exchange
NASDAQ

WKN A140ML
ISIN JE00BYSS4X48
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Ms. Ashley Cordova
Market Capitalization 2 Mrd.
Country Jersey
Currency USD
Employees 1,5 T
Address No. 4 The Forum, JE2 4UF Saint Helier
IPO Date 2015-10-01
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 038.F |
NASDAQ | NVCR |
More Shares
Investors who NOVOCURE LIMITED hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.